Critical Care Evidence Updates – October 2023
What’s new in the Critical Care literature – monthly updates
Continue reading »Year: 2023
Emergency Evidence Updates – October 2023
What’s new in the Critical Care literature – monthly updates
Continue reading »STRESS-L: Landiolol and Organ Failure in Patients With Septic Shock
Landiolol and Organ Failure in Patients With Septic Shock Whitehouse. JAMA Published online October 25, 2023. doi:10.1001/jama.2023.20134 Clinical Question In patients with tachycardia and septic shock who are treated with high dose norepinephrine does the use of β-blockade for up to 14 days reduce organ failure compared to standard care? Background Many view the use of β-blockade as contentious in […]
Continue reading »Emergency Department Resuscitative Endovascular Balloon Occlusion of the Aorta in Trauma Patients With Exsanguinating Hemorrhage
In trauma patients with exsanguinating haemorrhage, does the use of the REBOA (resuscitative endovascular balloon occlusion of the aorta) device with standard care in the emergency department, compared with standard care alone, impact 90-day-mortality?
Continue reading »Critical Care Evidence Updates – September 2023
What’s new in the Critical Care literature – monthly updates
Continue reading »Emergency Evidence Updates – September 2023
What’s new in the Critical Care literature – monthly updates
Continue reading »Early and Empirical High-Dose Cryoprecipitate for Hemorrhage After Traumatic Injury
In patients with trauma and critical bleeding who require activation of a major haemorrhage protocol, does the empiric administration of 3 pools of cryoprecipitate (6g fibrinogen) within 90 minutes of randomisation (and no more than 3 hours after injury) improve survival, compared to standard care?
Continue reading »ECLS-Shock – Extracorporeal Life Support in Infarct-Related Cardiogenic Shock
Extracorporeal Life Support in Infarct-Related Cardiogenic Shock Thiele H. NEJM 2023; Online ahead of print. doi:10.1056/NEJMoa2307227 Clinical Question In patients presenting with acute myocardial infarction complicated by cardiogenic shock undergoing revascularisation, does the early unselected application of extracorporeal life support reduce mortality from any cause at day 30? Background The use of venoarterial extracorporeal membrane oxygenation (VA ECMO), which is […]
Continue reading »Expedited transfer to a cardiac arrest centre for non-ST-elevation out-of-hospital cardiac arrest (ARREST)
In patients with non-ST elevation out-of-hospital cardiac arrest, does expedited delivery of patients to a cardiac arrest centre, compared with delivery to the geographically closest hospital, improve all-cause mortality at 30 days?
Continue reading »Critical Care Evidence Updates – July 2023
What’s new in the Critical Care literature – monthly updates
Continue reading »